Matthew Burkart, OD
Optometrist in Indianapolis, Indiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 60,484 in Optometrist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Matthew Burkart, OD reported a CMS MIPS final score of 95.6/100 - above the 83.1 national average - and filed 531 Medicare Part D claims in 2023.
- 95.6/100
- MIPS score · +12 vs avg
- 531
- Part D claims, 2023
- 42%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Matthew Burkart, OD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
96 Top 21% higher than 79% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Matthew Burkart, OD sits
This provider among optometrist peers
Across the 6,527 optometrist providers who report both Medicare Part D prescribing and a MIPS quality score, Matthew Burkart, OD writes more Part D claims than 65% of them and scores higher on MIPS quality than 79% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one optometrist peer from a representative sample of 60; the gold marker is Matthew Burkart, OD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Matthew Burkart, OD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Indiana
How Optometrist compares to other specialties among Indiana providers
Optometrist ranks #21 among Indiana's specialties (1.3% of in-state providers)
Each bar is a specialty's share of the Indiana provider total, by primary NUCC taxonomy. The highlighted bar is Optometrist; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Matthew Burkart, OD's 2023 MIPS final score plotted against the Optometrist national average
- MIPS Final Score
- 95.6/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Optometrist) - 95.6/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Optometrist US NPIs
95.6/100 MIPS final score - 12.5 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Optometrist. Quality dim: 100. Cost dim: 85.2.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Matthew Burkart, OD appears in the CMS NPPES registry as an Optometrist provider holding OD credentials at 1400 N RITTER AVE STE 281, Indianapolis, IN, 46219, with a listed phone of (317) 357-8663. NPI 1093077463 was issued on 06/12/2012.
Medicare Part D records for calendar year 2023 show 531 prescription claims written by this provider, covering 309 Medicare beneficiaries and totaling roughly $77K in drug spend, split 58% brand-name and 42% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 95.6/100 for the 2023 performance year (Quality 100, Cost 85.2), compared with the national average of 83.1.
Optometrist is a high-volume specialty nationwide, with 60,484 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1093077463 |
|---|---|
| Specialty | Optometrist |
| Credentials | OD |
| Gender | Male |
| NPI Issued | 06/12/2012 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Matthew Burkart, OD's current license status, disciplinary history, and board certifications with the Indiana Medical Licensing Board in Indiana before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1093077463 is the unique 10-digit identifier CMS uses to link Burkart across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Matthew Burkart, OD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Brand-heavy
58% brand-name claims vs 42% generic, on 531 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 774
- Total Day Supply
- 20,697
- Brand vs Generic
- 58% brand / 42% generic
- Brand Drug Cost
- $69K
- Generic Drug Cost
- $8K
Patient Demographics
- Average Patient Age
- 73.2 years
- Avg HCC Risk Score
- 1.32
- Gender Split
- 63% female / 37% male
- Age Distribution
- <65: 24, 65-74: 160, 75-84: 109, 85+: 16
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Matthew Burkart, OD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Prednisolone Acetate
Prednisolone Acetate
206 claims
- Latanoprost 61
Latanoprost
61 claims
- Dorzolamide-Timolol 40
Dorzolamide-Timolol
40 claims
- Brimonidine Tartrate 37
Brimonidine Tartrate
37 claims
- Ketorolac Trometha… 32
Ketorolac Tromethamine
32 claims
- Ofloxacin 28
Ofloxacin
28 claims
- Prolensa 25
Prolensa
25 claims
- Restasis 18
Restasis
18 claims
| Drug | Claims |
|---|---|
| Prednisolone Acetate | 206 |
| Latanoprost | 61 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 40 |
| Brimonidine Tartrate | 37 |
| Ketorolac Tromethamine | 32 |
| Ofloxacin | 28 |
| Prolensa Bromfenac Sodium | 25 |
| Restasis Cyclosporine | 18 |
| Timolol Maleate | 16 |
| Lumigan Bimatoprost | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Optometrist Overview
How Matthew Burkart, OD fits within the Optometrist landscape nationally.
Matthew Burkart, OD's 531 claims are above the specialty average of 257.
Nearby Optometrist Providers in Indiana
Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as Burkart.
Compare Optometrist nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Indiana medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Optometrist peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Indiana
Frequently Asked Questions
What is Matthew Burkart, OD's specialty? ▼
How much does Matthew Burkart, OD prescribe under Medicare Part D? ▼
What is Matthew Burkart, OD's Medicare quality score? ▼
Where is Matthew Burkart, OD located? ▼
What is Matthew Burkart, OD's NPI number? ▼
Does Matthew Burkart, OD prescribe more brand-name or generic drugs? ▼
How many Optometrist providers are there in the US? ▼
What drugs does Matthew Burkart, OD prescribe most often? ▼
Does Matthew Burkart, OD accept Medicare? ▼
How can I verify Matthew Burkart, OD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.